These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 20925474

  • 41. Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline.
    Kauser H, Sahu S, Kumar S, Panjwani U.
    Neuroscience; 2013 Dec 19; 254():110-9. PubMed ID: 24056194
    [Abstract] [Full Text] [Related]

  • 42. Right prefrontal brain activation due to Stroop interference is altered in attention-deficit hyperactivity disorder - A functional near-infrared spectroscopy study.
    Jourdan Moser S, Cutini S, Weber P, Schroeter ML.
    Psychiatry Res; 2009 Sep 30; 173(3):190-5. PubMed ID: 19664910
    [Abstract] [Full Text] [Related]

  • 43. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
    Gronier B.
    Eur Neuropsychopharmacol; 2011 Feb 30; 21(2):192-204. PubMed ID: 21146374
    [Abstract] [Full Text] [Related]

  • 44. Signaling mechanism underlying α2A -adrenergic suppression of excitatory synaptic transmission in the medial prefrontal cortex of rats.
    Yi F, Liu SS, Luo F, Zhang XH, Li BM.
    Eur J Neurosci; 2013 Aug 30; 38(3):2364-73. PubMed ID: 23701442
    [Abstract] [Full Text] [Related]

  • 45. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychopharmacol; 2008 Jun 30; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [Abstract] [Full Text] [Related]

  • 46. Stimulants: Therapeutic actions in ADHD.
    Arnsten AF.
    Neuropsychopharmacology; 2006 Nov 30; 31(11):2376-83. PubMed ID: 16855530
    [Abstract] [Full Text] [Related]

  • 47. Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals.
    Ramos BP, Stark D, Verduzco L, van Dyck CH, Arnsten AF.
    Learn Mem; 2006 Nov 30; 13(6):770-6. PubMed ID: 17101879
    [Abstract] [Full Text] [Related]

  • 48. N-methyl-d-aspartate receptor dysfunction in the prefrontal cortex of stroke-prone spontaneously hypertensive rat/Ezo as a rat model of attention deficit/hyperactivity disorder.
    Shikanai H, Oshima N, Kawashima H, Kimura SI, Hiraide S, Togashi H, Iizuka K, Ohkura K, Izumi T.
    Neuropsychopharmacol Rep; 2018 Jun 30; 38(2):61-66. PubMed ID: 30106260
    [Abstract] [Full Text] [Related]

  • 49. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Miller EM, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE.
    Psychopharmacology (Berl); 2014 Aug 30; 231(15):3019-29. PubMed ID: 24682500
    [Abstract] [Full Text] [Related]

  • 50. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
    Sallee F, Connor DF, Newcorn JH.
    J Child Adolesc Psychopharmacol; 2013 Jun 30; 23(5):308-19. PubMed ID: 23782125
    [Abstract] [Full Text] [Related]

  • 51. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
    Loo SK, Bilder RM, Cho AL, Sturm A, Cowen J, Walshaw P, Levitt J, Del'Homme M, Piacentini J, McGough JJ, McCracken JT.
    J Am Acad Child Adolesc Psychiatry; 2016 Aug 30; 55(8):674-682.e1. PubMed ID: 27453081
    [Abstract] [Full Text] [Related]

  • 52. Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders.
    Agster KL, Clark BD, Gao WJ, Shumsky JS, Wang HX, Berridge CW, Waterhouse BD.
    Anat Rec (Hoboken); 2011 Oct 30; 294(10):1698-712. PubMed ID: 21901844
    [Abstract] [Full Text] [Related]

  • 53. Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control.
    Schulz KP, Clerkin SM, Fan J, Halperin JM, Newcorn JH.
    Psychopharmacology (Berl); 2013 Mar 30; 226(2):261-71. PubMed ID: 23086020
    [Abstract] [Full Text] [Related]

  • 54. Prefrontal cortex dysfunction in hypoxic-ischaemic encephalopathy contributes to executive function impairments in rats: Potential contribution for attention-deficit/hyperactivity disorder.
    Miguel PM, Deniz BF, Deckmann I, Confortim HD, Diaz R, Laureano DP, Silveira PP, Pereira LO.
    World J Biol Psychiatry; 2018 Oct 30; 19(7):547-560. PubMed ID: 28105895
    [Abstract] [Full Text] [Related]

  • 55. Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model.
    Lukkes JL, Drozd HP, Fitz SD, Molosh AI, Clapp DW, Shekhar A.
    J Neurodev Disord; 2020 Jan 15; 12(1):2. PubMed ID: 31941438
    [Abstract] [Full Text] [Related]

  • 56. A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.
    Nilsson SRO, Celada P, Fejgin K, Thelin J, Nielsen J, Santana N, Heath CJ, Larsen PH, Nielsen V, Kent BA, Saksida LM, Stensbøl TB, Robbins TW, Bastlund JF, Bussey TJ, Artigas F, Didriksen M.
    Psychopharmacology (Berl); 2016 Jun 15; 233(11):2151-2163. PubMed ID: 26983414
    [Abstract] [Full Text] [Related]

  • 57. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
    Schmeichel BE, Zemlan FP, Berridge CW.
    Neuropharmacology; 2013 Jan 15; 64(1):321-8. PubMed ID: 22796428
    [Abstract] [Full Text] [Related]

  • 58. Guanfacine extended-release: in attention deficit hyperactivity disorder.
    Muir VJ, Perry CM.
    Drugs; 2010 Sep 10; 70(13):1693-702. PubMed ID: 20731476
    [Abstract] [Full Text] [Related]

  • 59. Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys.
    Ma CL, Arnsten AF, Li BM.
    Biol Psychiatry; 2005 Jan 15; 57(2):192-5. PubMed ID: 15652880
    [Abstract] [Full Text] [Related]

  • 60. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors.
    Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD.
    Biol Psychiatry; 2012 Mar 01; 71(5):467-73. PubMed ID: 21890109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.